tax inversion

Business Rebecca Robbins

The big winners and losers of the Pfizer-Allergan breakup

Pharmalot Ed Silverman

Awaiting approval for merger, Allergan touts economic impact study

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: US drug spending spikes, tax inversion opposition in NJ

Pharmalot Ed Silverman

Pfizer and Allergan to create the world’s largest drug maker

Politics Charles Piller

Pfizer exploiting Washington’s inaction on tax loophole